stockrowCalumet, Inc.
CLMT Basic Materials Specialty Chemicals
Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024.
- Revenue
- +40.8%
- EPS
- +35.9%
- Free cash flow
- +450.7%
- Total debt
- −1.98%
Quarter to June 2026, against a year earlier
Follow CLMT
Alert me
Calumet, Inc. (CLMT) EPS (diluted)
Calumet, Inc.'s EPS (diluted) for fiscal 2025 was −$0.39, compared with −$2.67 in fiscal 2024. Over the twelve months to 30 June 2026 it was −$1.55. Over the past ten years it has ranged from −$4.18 (fiscal 2016) to $0.59 (fiscal 2023); the current reading is higher than 91% of that period. Calumet, Inc. ranks 51st of 56 Specialty Chemicals companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$0.39 | — |
| FY2024 | −$2.67 | — |
| FY2023 | $0.59 | — |
| FY2022 | −$2.04 | — |
| FY2021 | −$3.23 | — |
| FY2020 | −$1.86 | — |
| FY2019 | −$0.55 | — |
| FY2018 | −$0.69 | — |
| FY2017 | −$1.31 | — |
| FY2016 | −$4.18 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | −$1.09 | — |
| Mar 2026 | −$3.64 | — |
| Dec 2025 | −$0.43 | — |
| Sep 2025 | $3.61 | — |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| WDFC WD-40 Company compare | $6.08 |
| CBT Cabot Corporation compare | $4.17 |
| HWKN Hawkins, Inc. compare | $4.12 |
| SXT Sensient Technologies Corporation compare | $3.97 |
| FUL H. B. Fuller Company compare | $3.59 |
| AVNT Avient Corporation compare | $1.96 |
| PRM Perimeter Solutions, SA compare | $0.13 |
| ASH Ashland Inc. compare | $0.08 |
| CLMT Calumet, Inc. | −$1.55 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CLMT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement